FDA rejects MDMA for treatment, a ‘major setback’ for focus of Bay Area research
-----
In a setback to the movement to mainstream psychedelics for medical use, the U.S. Food and Drug Administration has declined to approve what would have been the first federally regulated psychedelic drug for medical treatment.The therapy in question uses psychotherapy and MDMA, more commonly known as ecstasy or molly, to treat post-traumatic stress disorder, which affects millions of Americans and is difficult to manage with antidepressants and conventional therapy.
The company that
